AU4045097A - Transdermal transport of molecules - Google Patents

Transdermal transport of molecules

Info

Publication number: AU4045097A
Authority: AU; Australia
Prior art keywords: molecules; transdermal transport; transdermal; transport
Prior art date: 1996-07-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU40450/97A

Inventor

Wilson T. Crandall

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-23

Filing date

1997-07-23

Publication date

1998-02-10

1997-07-23 Application filed by Individual filed Critical Individual

1998-02-10 Publication of AU4045097A publication Critical patent/AU4045097A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Dermatology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)

AU40450/97A 1996-07-23 1997-07-23 Transdermal transport of molecules Abandoned AU4045097A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US68523596A	1996-07-23	1996-07-23
US08685235		1996-07-23
PCT/US1997/012970 WO1998003641A1 (en)	1996-07-23	1997-07-23	Transdermal transport of molecules

Publications (1)

Publication Number	Publication Date
AU4045097A true AU4045097A (en)	1998-02-10

Family

ID=24751308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU40450/97A Abandoned AU4045097A (en)	1996-07-23	1997-07-23	Transdermal transport of molecules

Country Status (4)

Country	Link
EP (1)	EP0958355A1 (en)
AU (1)	AU4045097A (en)
CA (1)	CA2262009A1 (en)
WO (1)	WO1998003641A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998031369A1 (en) *	1997-01-16	1998-07-23	Sekisui Chemical Co., Ltd.	External preparations for percutaneous absorption
US6348450B1 (en)	1997-08-13	2002-02-19	The Uab Research Foundation	Noninvasive genetic immunization, expression products therefrom and uses thereof
KR20080009171A (en) *	1997-08-13	2008-01-24	더 유에이비 리서치 파운데이션	Vaccination by Topical Application of Gene Vectors
AU1261501A (en) *	1999-12-06	2001-06-18	Stanley L. Gore	Compositions and methods for intranasal delivery of active agents to the brain
EP2907503A1 (en)	2003-04-10	2015-08-19	Neurogesx, Inc.	Methods and compositions for administration of TRPV1 agonists
MX2007010306A (en)	2005-02-23	2007-09-26	Uab Research Foundation	Alkyl-glycoside enhanced vaccination.
NZ552816A (en) *	2007-01-24	2009-05-31	Bomac Research Ltd	Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
WO2009101412A1 (en) *	2008-02-13	2009-08-20	Cipla Limited	Topical pharmaceutical composition
EP2210589B1 (en) *	2009-01-22	2015-05-06	Ludwig-Maximilians-Universität München	Vesicular phospholipid gels comprising proteinaceous substances
WO2011156803A2 (en) *	2010-06-11	2011-12-15	Transdel Pharmaceuticals, Inc.	Anti-cellulite composition and method of treating cellulite
CN109200013A (en) *	2011-12-05	2019-01-15	因赛普特有限责任公司	Medical organogel method and composition
WO2015051264A1 (en)	2013-10-03	2015-04-09	Imprimis Pharmaceuticals, Inc.	Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricatiing thereof
CA2972065A1 (en) *	2014-12-23	2016-06-30	Intellectual Property Associates, Llc	Methods and formulations for transdermal administration
WO2017127834A1 (en) *	2016-01-23	2017-07-27	Sand Bruce J	Enhanced transdermal delivery of active agents
MX2021015830A (en) *	2019-06-18	2022-04-11	Dyve Biosciences Inc	Transdermal penetrant formulations.
US20240009320A1 (en) *	2020-11-25	2024-01-11	DePuy Synthes Products, Inc.	Biocompatible organogel matrices for preparation of a drug delivery depot

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5264219A (en) *	1992-08-07	1993-11-23	Minnesota Mining And Manufacturing Company	Transdermal drug delivery backing

1997
- 1997-07-23 WO PCT/US1997/012970 patent/WO1998003641A1/en not_active Ceased
- 1997-07-23 EP EP97938029A patent/EP0958355A1/en not_active Withdrawn
- 1997-07-23 AU AU40450/97A patent/AU4045097A/en not_active Abandoned
- 1997-07-23 CA CA 2262009 patent/CA2262009A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2262009A1 (en)	1998-01-29
WO1998003641A1 (en)	1998-01-29
EP0958355A1 (en)	1999-11-24

Publication	Publication Date	Title
AU9790198A (en)	1999-04-27	Compounds and methods
AU4261697A (en)	1998-03-26	Compounds and methods
AU5268696A (en)	1996-11-07	Novel compounds and methods for therapy
AUPO274696A0 (en)	1996-10-31	Transportable structure
AU2644497A (en)	1997-11-07	Biosensors
AU3539297A (en)	1998-02-09	Transdermal therapeutic systems
AU4045097A (en)	1998-02-10	Transdermal transport of molecules
AU3011397A (en)	1997-11-26	Water-stabilized organosilane compounds and methods for using the same
AU1184399A (en)	1999-05-31	Therapeutic molecules
AU5095698A (en)	1998-05-15	Transdermal patch
AU9636598A (en)	1999-05-24	Treatment of organic materials
AU6657396A (en)	1997-02-26	Transdermal system
AU5084498A (en)	1998-05-05	Wheel support
AU4727297A (en)	1998-06-10	Novel antitumor compounds and use thereof
AU4302497A (en)	1998-04-14	Metalocarboxypeptidase inhibitors and derived molecules as antitumoural agents
AU6899196A (en)	1997-10-01	Arginase ii
AU2907597A (en)	1997-12-09	Paper treatment
AU727267C (en)	2001-06-28	Patch for transdermal application of pergolid
AU4104997A (en)	1998-04-02	Therapeutic molecules
AUPO226296A0 (en)	1996-10-03	Therapeutic molecules
AU4124497A (en)	1998-03-26	Treatment of diabetes
HK1028553A (en)	2001-02-23	Compounds and methods
AU3532797A (en)	1998-02-20	Biosensors
AUPP096197A0 (en)	1998-01-15	Novel molecules and uses thereof-iv
AUPO642097A0 (en)	1997-05-22	Novel molecules and uses thereof-II